China Life Investment
11th Floor, China Life Center, No. 17 Financial Street, Beijing, Xicheng District, 100033, China
Overview
China Life Investment Holding is an investment platform for China Life’s magnificent vision in healthcare sector, focusing on investment opportunities of premiu-quality companies along the industry chain of healthcare. It is committed to give full play to the driving role of commercial insurance, and deeply promote the integration and development of healthcare and insurance service, so as to meet diversified medical service and insurance protection demands of customers. Leveraging China Life’s massive resources, the Company can enrich portfolio companies’ customer base and provide insurance solutions integrally hence accelerating developments of portfolio companies. In addition, through cooperation and collaboration with portfolio companies, China Life can better serve its customers with premium-quality, convenient and integrated insurance, healthcare and medical solutions, and make a contribution to healthcare industry’s development and evolvement in China.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 0
Sector focus
- Finance
- Financial Services
- Health Care
Investment portfolio
- FAIRINO
Led · Series C · Mar 2026
FAIRINO develops collaborative robots (cobots) and smart manufacturing solutions with full-stack in-house R&D for core components such as controllers, encoders, servo drivers, harmonic reducers, servo motors, and braking systems. Its FR series of cobots spans 11 models with payloads from 3 to 35 kg, and its product lineup has expanded to include the WM series for welding and the C series for commercial applications. The company serves tasks including CNC loading and unloading, palletizing, welding and grinding, assembly inspection, and commercial services, and counts clients such as Samsung, Hyundai, AISIN, Unilever, and DENSO. FAIRINO has built a global network of over 50 overseas sales points and three service centers and has partnerships with channel partners like igus and MISUMI. Looking toward 2026, the company is shifting to an "AI + Cobot" strategy to drive embodied intelligence and is accelerating entry into the humanoid robot sector with the aim of positioning itself as a Tier 1 core supplier for humanoid manufacturers.
Team
No current team members are available.